Featured Research

from universities, journals, and other organizations

Life Saving Discrepancy: Study Shows Effectiveness Of Mismatched Bone Marrow Transplants

Date:
October 23, 1998
Source:
Weizmann Institute Of Science
Summary:
Scientists from Israel's Weizmann Institute of Science and Perugia University in Italy have shown that thanks to a method they developed, transplants using mismatched marrow can be as effective as those in which the donor and recipient are fully matched.

REHOVOT, Israel - October 22, 1998 - For many leukemia sufferers, bone marrow transplantation is their only hope. Unfortunately, in about 40 percent of terminal cases, patients fail to find a perfectly matched donor among relatives or in any of the donor registries.

Now, scientists from Israel's Weizmann Institute of Science and Perugia University in Italy have shown that thanks to a method they developed, transplants using mismatched marrow can be as effective as those in which the donor and recipient are fully matched. The results of their latest study, reported in the October 22 issue of the New England Journal of Medicine, have raised hopes that one day a donor will be found for virtually every candidate for a bone marrow transplant.

Normally, a donor and recipient are considered compatible when they are matched for all six immunological markers on their chromosomes - three inherited from the mother and three from the father. In the method developed by a team headed by Prof. Yair Reisner of Weizmann's Immunology Department and Prof. Massimo Martelli of Perugia's Policlinico Monteluce, the donor and the recipient need to be matched for only three markers.

Such a partial match is always found between parents and children, and there is a 75-percent chance of finding it between siblings. Even among the extended family, the chances of finding a partially compatible donor are fairly good.

A key element of the Weizmann-Perugia method is the use of extremely large doses of donor marrow. The donor is treated with hormone injections that release large numbers of stem cells from the bone marrow into the bloodstream. In a procedure known as leukapheresis, the stem cells are selectively removed from blood withdrawn from the body, and the remaining blood is re-infused to the donor. In another crucial step, donated stem cells are then "cleansed" to erase the characteristics that contribute to rejection in mismatched transplants.

In the study, the Perugia-Weizmann team traces the results of dozens of such mismatched transplants performed on patients with high-risk acute myeloid leukemia or acute lymphoid leukemia between 1995 and 1997.

Of the 43 patients treated, 16 were free of disease when the study results were summed up. To appreciate this figure, one must keep in mind that all patients had failed to respond to any other treatment, and without a transplant would have certainly died. The rest of the patients were alive but had a relapse of leukemia, or had died of the disease or of transplant-related complications.

These results are similar to the success rate obtained in this category of patients with perfectly matched transplants from unrelated donors.

According to the scientists, the study shows that their method overcomes the main obstacles limiting the use of mismatched transplants - namely, graft failure and an adverse immunological reaction called graft-versus-host disease.

"Since most patients have a mismatched relative (who can serve as a bone marrow donor), advances in this area will greatly increase the availability of transplants as curative therapy," the researchers conclude in their report.

Several hospitals in Israel, Germany, Austria and the United States have begun to introduce the Perugia-Weizmann transplantation method.

In January 1999, Prof. Reisner and Prof. Martelli will host an international symposium in Eilat, Israel, for some 60 physicians interested in applying the new method. The participants, most of them heads of transplantation departments in their respective hospitals, will come from Austria, Denmark, France, Germany, Israel, Italy, Spain, Switzerland, The Netherlands, United Kingdom and United States.

Prof. Reisner holds the Henry H. Drake Professorial Chair in Immunology at the Weizmann Institute. This research was funded in part by Rowland Schaefer, Miami, Florida; the Pauline Fried Estate, Los Angeles, California; the Concern Foundation, Los Angeles, California; the Israel Academy of Sciences and Humanities; Comitato per la Vita "Daniele Chianelli"; Associazione Italiana Ricerche sul Cancro (AIRC); Associazione Italiana Leucemie e Linfomi (AIL), and Istituto Superiore di Sanita, Italy-USA Program on Therapy of Tumors.

The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,400 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of the human condition. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high priorities.


Story Source:

The above story is based on materials provided by Weizmann Institute Of Science. Note: Materials may be edited for content and length.


Cite This Page:

Weizmann Institute Of Science. "Life Saving Discrepancy: Study Shows Effectiveness Of Mismatched Bone Marrow Transplants." ScienceDaily. ScienceDaily, 23 October 1998. <www.sciencedaily.com/releases/1998/10/981023072444.htm>.
Weizmann Institute Of Science. (1998, October 23). Life Saving Discrepancy: Study Shows Effectiveness Of Mismatched Bone Marrow Transplants. ScienceDaily. Retrieved August 2, 2014 from www.sciencedaily.com/releases/1998/10/981023072444.htm
Weizmann Institute Of Science. "Life Saving Discrepancy: Study Shows Effectiveness Of Mismatched Bone Marrow Transplants." ScienceDaily. www.sciencedaily.com/releases/1998/10/981023072444.htm (accessed August 2, 2014).

Share This




More Health & Medicine News

Saturday, August 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins